(CELH) Celsius Holdings - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US15118V2079
Functional Energy Drinks, Hydration Powders, Ready-To-Drink
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 83.4% |
| Value at Risk 5%th | 114% |
| Relative Tail Risk | -16.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | 31.26 |
| CAGR/Max DD | 0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.860 |
| Beta Downside | 0.878 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.86% |
| Mean DD | 35.48% |
| Median DD | 30.40% |
Description: CELH Celsius Holdings October 30, 2025
Celsius Holdings, Inc. (NASDAQ: CELH) designs, manufactures, markets and distributes a portfolio of functional energy and hydration beverages-including CELSIUS Originals, Vibe, Essentials, On-the-Go Powder, and Hydration powders-across the United States, North America, Europe, Asia-Pacific and other international markets. Distribution channels span direct-to-store delivery, independent distributors, supermarkets, convenience and drug stores, specialty nutrition retailers, food-service operators, gyms, mass-market chains and e-commerce platforms.
Recent performance highlights include FY 2023 net revenue of approximately $1.8 billion, representing a 45 % year-over-year increase driven largely by strong volume growth in the on-premise (gym and fitness-center) segment and expanding e-commerce sales. The brand’s “zero-sugar, thermogenic” positioning aligns with the broader health-conscious beverage trend, which the Beverage Marketing Corporation estimates will sustain a CAGR of ~5 % through 2027. However, competitive pressure from larger soft-drink conglomerates and the need for continuous innovation in flavor and functional claims remain material risk factors.
For a deeper quantitative view of CELH’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (64.4m TTM) > 0 and > 6% of Revenue (6% = 127.6m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -0.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 42.93% (prev 78.35%; Δ -35.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 554.6m > Net Income 64.4m (YES >=105%, WARN >=100%) |
| Net Debt (55.5m) to EBITDA (129.6m) ratio: 0.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (237.2m) change vs 12m ago 1.49% (target <= -2.0% for YES) |
| Gross Margin 51.38% (prev 49.59%; Δ 1.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 61.00% (prev 80.43%; Δ -19.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.94 (EBITDA TTM 129.6m / Interest Expense TTM 36.3m) >= 6 (WARN >= 3) |
Altman Z'' 1.52
| (A) 0.17 = (Total Current Assets 1.94b - Total Current Liabilities 1.03b) / Total Assets 5.27b |
| (B) 0.03 = Retained Earnings (Balance) 165.5m / Total Assets 5.27b |
| (C) 0.03 = EBIT TTM 106.7m / Avg Total Assets 3.49b |
| (D) 0.07 = Book Value of Equity 168.1m / Total Liabilities 2.30b |
| Total Rating: 1.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.96
| 1. Piotroski 4.0pt |
| 2. FCF Yield 5.18% |
| 3. FCF Margin 24.63% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda 0.43 |
| 6. ROIC - WACC (= -2.70)% |
| 7. RoE 3.41% |
| 8. Rev. Trend 89.47% |
| 9. EPS Trend 35.36% |
What is the price of CELH shares?
As of December 08, 2025, the stock is trading at USD 42.06 with a total of 4,303,489 shares traded.
Over the past week, the price has changed by +2.74%, over one month by -29.81%, over three months by -27.94% and over the past year by +50.81%.
Over the past week, the price has changed by +2.74%, over one month by -29.81%, over three months by -27.94% and over the past year by +50.81%.
Is CELH a buy, sell or hold?
Celsius Holdings has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CELH.
- Strong Buy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CELH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.5 | 53.4% |
| Analysts Target Price | 64.5 | 53.4% |
| ValueRay Target Price | 42.5 | 1% |
CELH Fundamental Data Overview November 25, 2025
Market Cap USD = 10.05b (10.05b USD * 1.0 USD.USD)
P/E Trailing = 324.9167
P/E Forward = 25.1256
P/S = 4.728
P/B = 8.3542
P/EG = 0.6106
Beta = 0.971
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 10.11b USD (10.05b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
FCF Yield = 5.18% (FCF TTM 523.6m / Enterprise Value 10.11b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 1.92 (Enterprise Value 10.11b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 30.69% (-27.0m / -88.0m)
NOPAT = 74.0m (EBIT 106.7m * (1 - 30.69%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 5.87% (NOPAT 74.0m / Invested Capital 1.26b)
WACC = 8.57% (E(10.05b)/V(10.91b) * Re(9.18%) + D(861.5m)/V(10.91b) * Rd(2.12%) * (1-Tc(0.31)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 74.96% ; FCFE base≈382.0m ; Y1≈399.2m ; Y5≈462.6m
Fair Price DCF = 25.72 (DCF Value 6.63b / Shares Outstanding 257.8m; 5y FCF grow 4.81% → 3.0% )
EPS Correlation: 35.36 | EPS CAGR: 4.73% | SUE: 1.01 | # QB: 1
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.29 | Chg30d=-0.017 | Revisions Net=+2 | Analysts=10
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=+22.8% | Growth Revenue=+32.0%
P/E Trailing = 324.9167
P/E Forward = 25.1256
P/S = 4.728
P/B = 8.3542
P/EG = 0.6106
Beta = 0.971
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 10.11b USD (10.05b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
FCF Yield = 5.18% (FCF TTM 523.6m / Enterprise Value 10.11b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 1.92 (Enterprise Value 10.11b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 30.69% (-27.0m / -88.0m)
NOPAT = 74.0m (EBIT 106.7m * (1 - 30.69%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 5.87% (NOPAT 74.0m / Invested Capital 1.26b)
WACC = 8.57% (E(10.05b)/V(10.91b) * Re(9.18%) + D(861.5m)/V(10.91b) * Rd(2.12%) * (1-Tc(0.31)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 74.96% ; FCFE base≈382.0m ; Y1≈399.2m ; Y5≈462.6m
Fair Price DCF = 25.72 (DCF Value 6.63b / Shares Outstanding 257.8m; 5y FCF grow 4.81% → 3.0% )
EPS Correlation: 35.36 | EPS CAGR: 4.73% | SUE: 1.01 | # QB: 1
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.29 | Chg30d=-0.017 | Revisions Net=+2 | Analysts=10
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=+22.8% | Growth Revenue=+32.0%
Additional Sources for CELH Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle